Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5735-53-5

Post Buying Request

5735-53-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5735-53-5 Usage

Uses

It is used as pharmaceutical intermediate. Benzoylthiophenes are allosteric enhancers (AE) of agonist activity at the A1 adenosine receptor.

Check Digit Verification of cas no

The CAS Registry Mumber 5735-53-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,3 and 5 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 5735-53:
(6*5)+(5*7)+(4*3)+(3*5)+(2*5)+(1*3)=105
105 % 10 = 5
So 5735-53-5 is a valid CAS Registry Number.
InChI:InChI=1/C52H61N3O11/c1-28-16-15-17-29(2)51(63)53-40-42(55-25-23-54(24-26-55)41(34-18-11-9-12-19-34)35-20-13-10-14-21-35)48(61)37-38(47(40)60)46(59)33(6)49-39(37)50(62)52(7,66-49)65-27-22-36(64-8)30(3)44(57)32(5)45(58)31(4)43(28)56/h9-22,27-28,30-32,36,41,43-45,56-59H,23-26H2,1-8H3,(H,53,63)

5735-53-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H33641)  3,4-Dihydro-2H-1,4-benzoxazine, 97%   

  • 5735-53-5

  • 1g

  • 1070.0CNY

  • Detail
  • Alfa Aesar

  • (H33641)  3,4-Dihydro-2H-1,4-benzoxazine, 97%   

  • 5735-53-5

  • 5g

  • 3755.0CNY

  • Detail

5735-53-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Benzomorpholine

1.2 Other means of identification

Product number -
Other names 3,4-dihydro-2H-1,4-benzoxazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5735-53-5 SDS

5735-53-5Synthetic route

1-(2H-benzo[b][1,4]oxazin-4(3H)-yl)ethanone
70801-52-4

1-(2H-benzo[b][1,4]oxazin-4(3H)-yl)ethanone

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With sodium bis(2-methoxyethoxy)aluminium dihydride In toluene at -40℃; for 1.16667h;100%
With sodium triethylborohydride In tetrahydrofuran at 80℃; for 12h; Inert atmosphere; Schlenk technique; Glovebox; Sealed tube;81%
With sodium triethylborohydride In tetrahydrofuran at 80℃; for 6h; Inert atmosphere; Schlenk technique; High pressure; Sealed tube;81%
(2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)(phenyl)methanone
19202-00-7

(2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)(phenyl)methanone

A

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

B

benzaldehyde
100-52-7

benzaldehyde

Conditions
ConditionsYield
With sodium bis(2-methoxyethoxy)aluminium dihydride In ethyl acetate; benzene at -40℃;A 100%
B 100%
2-(2-aminophenoxy)ethan-1-ol
42876-07-3

2-(2-aminophenoxy)ethan-1-ol

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With [RuCl2(N-heterocyclic carbene)(bis[2-(diphenylphosphino)ethyl]amine)]; hydrogen; caesium carbonate In toluene; butan-1-ol at 120℃; under 22502.3 Torr; for 6h; Schlenk technique; Autoclave;100%
3,4-dihydro-3-oxo-2H-1,4-benzoxazine
5466-88-6

3,4-dihydro-3-oxo-2H-1,4-benzoxazine

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With [RuCl2(N-heterocyclic carbene)(bis[2-(diphenylphosphino)ethyl]amine)]; hydrogen; caesium carbonate In toluene; butan-1-ol at 120℃; under 22502.3 Torr; for 6h; Schlenk technique; Autoclave;98%
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 2h; Inert atmosphere;92%
Stage #1: 3,4-dihydro-3-oxo-2H-1,4-benzoxazine With lithium aluminium tetrahydride In tetrahydrofuran Heating / reflux;
Stage #2: With sodium hydroxide; water In tetrahydrofuran
79%
1-(2H-benzo[b][1,4]oxazin-4(3H)-yl)ethanone
70801-52-4

1-(2H-benzo[b][1,4]oxazin-4(3H)-yl)ethanone

A

4-ethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine
82756-78-3

4-ethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine

B

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With triethyl borane; Triethoxysilane; sodium hydroxide In hexane at 80℃; for 6h; Reagent/catalyst; Solvent; Inert atmosphere; Sealed tube;A 7%
B 90%
With Triethoxysilane; sodium triethylborohydride In hexane at 80℃; for 6h; Schlenk technique; Glovebox; Sealed tube; Inert atmosphere;A 90%
B n/a
With Triethoxysilane; sodium triethylborohydride In hexane at 80℃; for 6h; Inert atmosphere; Schlenk technique; High pressure; Sealed tube;A 90%
B n/a
2-(2-nitrophenoxy)acetonitrile
31507-30-9

2-(2-nitrophenoxy)acetonitrile

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen; toluene-4-sulfonic acid In ethanol at 50℃; under 37503.8 Torr; for 2h;88%
With polymethylhydrosiloxane; palladium dihydroxide In ethanol at 20℃; for 0.5h;73%
2-<(2-bromophenyl)amino>ethanol
87762-20-7

2-<(2-bromophenyl)amino>ethanol

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With racemic-2-(di-tert-butylphosphino)-1,1′-binaphthyl; palladium diacetate; caesium carbonate In toluene at 50℃; for 24h;87%
With racemic-2-(di-tert-butylphosphino)-1,1′-binaphthyl; palladium diacetate; caesium carbonate In toluene at 50℃; for 24h;87%
4-(p-toluenesulfonyl)-3,4-dihydro-2H-benzoxazine
438013-84-4

4-(p-toluenesulfonyl)-3,4-dihydro-2H-benzoxazine

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With naphthalene; tetraethylammonium bromide In N,N-dimethyl-formamide at 0℃; Inert atmosphere; Electrolysis;87%
tert-butyl (2-phenoxyethyl)(tosyloxy)carbamate

tert-butyl (2-phenoxyethyl)(tosyloxy)carbamate

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]}; trifluoroacetic acid In 2,2,2-trifluoroethanol at 0 - 20℃; for 17h; regioselective reaction;82%
With Rh2(esp)2; trifluoroacetic acid In 2,2,2-trifluoroethanol at 20℃; for 17h; Inert atmosphere;82%
benzofuran-3(2H)-one oxime
82415-84-7

benzofuran-3(2H)-one oxime

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Stage #1: benzofuran-3(2H)-one oxime With diisobutylaluminium hydride In hexane; dichloromethane at 0 - 20℃; Inert atmosphere;
Stage #2: With sodium fluoride In hexane; dichloromethane; water at 0℃; for 0.5h;
80%
Stage #1: benzofuran-3(2H)-one oxime With diisobutylaluminium hydride In hexane; dichloromethane at 0 - 20℃; Inert atmosphere;
Stage #2: With water; sodium fluoride In hexane; dichloromethane at 0℃; for 0.5h; Inert atmosphere; regioselective reaction;
80%
With diisobutylaluminium hydride In dichloromethane at 0 - 20℃;80%
ethylene dibromide
106-93-4

ethylene dibromide

2-amino-phenol
95-55-6

2-amino-phenol

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 125℃; for 15h;73%
With potassium carbonate In N,N-dimethyl-formamide at 125℃; for 15h;65%
With potassium carbonate In dimethyl sulfoxide at 80℃;62%
2-amino-phenol
95-55-6

2-amino-phenol

(2-bromoethyl)(diphenyl)sulfonium trifluoromethanesulfonate

(2-bromoethyl)(diphenyl)sulfonium trifluoromethanesulfonate

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Stage #1: 2-amino-phenol With sodium hydride In dichloromethane at 0℃; for 0.0833333h; Inert atmosphere;
Stage #2: (2-bromoethyl)(diphenyl)sulfonium trifluoromethanesulfonate In dichloromethane at 25 - 30℃; for 15h; Inert atmosphere;
68%
2-allyloxy-1-nitrobenzene
55339-51-0

2-allyloxy-1-nitrobenzene

A

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

B

4-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine
77901-22-5

4-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine

Conditions
ConditionsYield
Stage #1: 2-allyloxy-1-nitrobenzene With ozone In methanol at -78℃;
Stage #2: With hydrogen; nitrobenzene; palladium on activated charcoal In methanol at 25℃; under 3040 Torr; for 6h;
A 66%
B n/a
1-(2-chloroethoxy)-2-nitrobenzene
102236-25-9

1-(2-chloroethoxy)-2-nitrobenzene

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Stage #1: 1-(2-chloroethoxy)-2-nitrobenzene With platinum(IV) oxide; hydrogen; sodium acetate In ethyl acetate at 25℃; under 7500.75 Torr; for 2h;
Stage #2: With triethylamine; sodium iodide In ethyl acetate for 16h; Reflux;
37%
4-acetyl-4H-1,4-benzoxazine
70801-51-3

4-acetyl-4H-1,4-benzoxazine

A

4-ethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine
82756-78-3

4-ethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine

B

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With lithium aluminium tetrahydride; hydrogen; palladium on activated charcoal 1.) Et2O, 20 deg C, 30 min, 2.) ethanol; Yield given. Multistep reaction. Yields of byproduct given;
2-<β-chloro-ethylamino>-phenol

2-<β-chloro-ethylamino>-phenol

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With sodium hydroxide
ethylene dibromide
106-93-4

ethylene dibromide

2-amino-phenol
95-55-6

2-amino-phenol

A

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

B

2-aziridin-1-yl-phenol

2-aziridin-1-yl-phenol

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 80℃; for 8h; Title compound not separated from byproducts;
2-(2-chlorophenoxy)ethylamine
26378-53-0

2-(2-chlorophenoxy)ethylamine

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With sodium hydride; tert-butyl alcohol; 1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene monohydrochloride; palladium diacetate In 1,4-dioxane for 4h;
4-(tert-butoxycarbonyl)-3,4-dihydro-2H-1,4-benzoxazine
212180-23-9

4-(tert-butoxycarbonyl)-3,4-dihydro-2H-1,4-benzoxazine

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
With hydrogenchloride In acetonitrile
Stage #1: 4-(tert-butoxycarbonyl)-3,4-dihydro-2H-1,4-benzoxazine With trifluoroacetic acid In dichloromethane at 20℃;
Stage #2: With sodium hydrogencarbonate In dichloromethane; water
1-(2-bromoethoxy)-2-chlorobenzene
18800-26-5

1-(2-bromoethoxy)-2-chlorobenzene

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: NaN3 / dimethylformamide / 2.5 h / 110 °C
2.1: PPh3 / tetrahydrofuran / 15 h / 20 °C
2.2: 63 percent / H2O / tetrahydrofuran / 3 h / 20 °C
3.1: N,N'-bis(2,6-diisopropylphenyl)dihydroimidazol-2-ylidene*HCl; NaH; t-BuOH / Pd(OAc)2 / dioxane / 4 h
View Scheme
2-monochlorophenol
95-57-8

2-monochlorophenol

(+-)-ethylphosphonic acid ethyl ester chloride

(+-)-ethylphosphonic acid ethyl ester chloride

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: aq. NaOH / 6 h / 100 °C
2.1: NaN3 / dimethylformamide / 2.5 h / 110 °C
3.1: PPh3 / tetrahydrofuran / 15 h / 20 °C
3.2: 63 percent / H2O / tetrahydrofuran / 3 h / 20 °C
4.1: N,N'-bis(2,6-diisopropylphenyl)dihydroimidazol-2-ylidene*HCl; NaH; t-BuOH / Pd(OAc)2 / dioxane / 4 h
View Scheme
1-(2-azidoethoxy)-2-chlorobenzene
66443-61-6

1-(2-azidoethoxy)-2-chlorobenzene

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: PPh3 / tetrahydrofuran / 15 h / 20 °C
1.2: 63 percent / H2O / tetrahydrofuran / 3 h / 20 °C
2.1: N,N'-bis(2,6-diisopropylphenyl)dihydroimidazol-2-ylidene*HCl; NaH; t-BuOH / Pd(OAc)2 / dioxane / 4 h
View Scheme
N-(2-(tert-butyldimethylsiloxy)-ethyl)-2-bromoaniline
325147-53-3

N-(2-(tert-butyldimethylsiloxy)-ethyl)-2-bromoaniline

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 96 percent / TBAF / tetrahydrofuran / 1 h
2: 87 percent / Pd(OAc)2; Cs2CO3; 2-(di-tert-butylphosphanyl)-1,1'-binaphthyl / toluene / 24 h / 50 °C
View Scheme
Multi-step reaction with 2 steps
1: 96 percent / TBAF / tetrahydrofuran / 1 h
2: 87 percent / Pd(OAc)2; di-tert-butyl-[2-(1,1'-binnaphthyl)]phosphine; Cs2CO3 / toluene / 24 h / 50 °C
View Scheme
2-amino-phenol
95-55-6

2-amino-phenol

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium hydrogencarbonate; N-benzyl-N,N,N-triethylammonium chloride / chloroform / 11 h / 0 - 55 °C
2.1: lithium aluminium tetrahydride / tetrahydrofuran / 20 °C / Reflux
2.2: 0 °C
View Scheme
Multi-step reaction with 3 steps
1: potassium carbonate / water; tetrahydrofuran / 1 h / -10 °C
2: potassium tert-butylate / dichloromethane; isopropyl alcohol / 1 h / 0 - 20 °C
3: lithium aluminium tetrahydride / tetrahydrofuran / 16 h / 0 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / acetonitrile / 20 h / Reflux
2: lithium aluminium tetrahydride / tetrahydrofuran / 2 h / 0 - 20 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / acetonitrile / 80 °C
2: lithium aluminium tetrahydride / tetrahydrofuran / 0 °C / Inert atmosphere
View Scheme
3-oxo-2,3-dihydrobenzo[b]furan
7169-34-8

3-oxo-2,3-dihydrobenzo[b]furan

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: methanesulfonic acid; sodium azide / 1.25 h / 0 - 20 °C
2: lithium aluminium tetrahydride / diethyl ether; tetrahydrofuran / 16 h / Reflux
View Scheme
N-(2-hydroxyphenyl)-2-chloroacetamide
10147-68-9

N-(2-hydroxyphenyl)-2-chloroacetamide

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium tert-butylate / dichloromethane; isopropyl alcohol / 1 h / 0 - 20 °C
2: lithium aluminium tetrahydride / tetrahydrofuran / 16 h / 0 - 20 °C
View Scheme
2-hydroxynitrobenzene
88-75-5

2-hydroxynitrobenzene

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: acetic acid; iron / ethanol; water
2: potassium carbonate / acetonitrile / 20 h / Reflux
3: lithium aluminium tetrahydride / tetrahydrofuran / 2 h / 0 - 20 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1.1: potassium carbonate / 1-methyl-pyrrolidin-2-one / 16 h / 120 °C
2.1: toluene-4-sulfonic acid; palladium 10% on activated carbon; hydrogen / 1,4-dioxane / 25 - 100 °C / 22502.3 Torr
2.2: 2 h / 50 °C / 30003 Torr
View Scheme
Multi-step reaction with 2 steps
1.1: potassium carbonate / acetonitrile / 2.5 h / Reflux
2.1: hydrogen; platinum(IV) oxide; sodium acetate / ethyl acetate / 2 h / 25 °C / 7500.75 Torr
2.2: 16 h / Reflux
View Scheme
1-(2-bromoethoxy)-2-nitrobenzene
18800-37-8

1-(2-bromoethoxy)-2-nitrobenzene

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Stage #1: 1-(2-bromoethoxy)-2-nitrobenzene With platinum(IV) oxide; hydrogen; sodium acetate In ethyl acetate at 25℃; under 7500.75 Torr; for 18h;
Stage #2: With triethylamine In ethyl acetate for 6h; Reflux;
2,2-Diethoxy-1-(o-nitrophenoxy)ethan
61144-93-2

2,2-Diethoxy-1-(o-nitrophenoxy)ethan

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Conditions
ConditionsYield
Stage #1: 2,2-Diethoxy-1-(o-nitrophenoxy)ethan With palladium 10% on activated carbon; hydrogen; toluene-4-sulfonic acid In 1,4-dioxane at 25 - 100℃; under 22502.3 Torr;
Stage #2: With hydrogenchloride; hydrogen In 1,4-dioxane; water at 50℃; under 30003 Torr; for 2h;
1,4-benzoxazine
5735-53-5

1,4-benzoxazine

chloroacetyl chloride
79-04-9

chloroacetyl chloride

2-chloro-1-(2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)ethan-1-one
22178-82-1

2-chloro-1-(2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)ethan-1-one

Conditions
ConditionsYield
With pyridine In benzene Ambient temperature;100%
With triethylamine In tetrahydrofuran at 20℃; for 2h; Inert atmosphere;76%
With TEA In chloroform at 20℃; for 18h;
1,4-benzoxazine
5735-53-5

1,4-benzoxazine

ethyl bromoacetate
105-36-2

ethyl bromoacetate

(2,3-dihydro-benzo[1,4]oxazin-4-yl)-acetic acid ethyl ester
903161-55-7

(2,3-dihydro-benzo[1,4]oxazin-4-yl)-acetic acid ethyl ester

Conditions
ConditionsYield
With potassium carbonate; sodium iodide In N,N-dimethyl-formamide at 125℃;99%
3-chlorothiophene
17249-80-8

3-chlorothiophene

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

4-(thiophen-3-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine

4-(thiophen-3-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine

Conditions
ConditionsYield
With 2-dicyclohexylphosphino-2′,6′-diisopropoxybiphenyl; potassium carbonate; ruphos In tert-Amyl alcohol at 110℃; for 20h; Schlenk technique; Inert atmosphere;98%
With 2-dicyclohexylphosphino-2′,6′-diisopropoxybiphenyl; potassium carbonate; ruphos In tert-Amyl alcohol at 110℃; for 20h; Inert atmosphere;98%
(1-cyanopropyl)(4-methoxyphenyl)carbamic chloride

(1-cyanopropyl)(4-methoxyphenyl)carbamic chloride

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

N-(1-cyanopropyl)-N-(4-methoxyphenyl)-2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carboxamide

N-(1-cyanopropyl)-N-(4-methoxyphenyl)-2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carboxamide

Conditions
ConditionsYield
With 2,6-dimethylpyridine; potassium iodide In acetonitrile at 120℃; for 4h; Microwave irradiation;98%
formaldehyd
50-00-0

formaldehyd

C12H12N2O

C12H12N2O

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

C21H21N3O2

C21H21N3O2

Conditions
ConditionsYield
With C38H38N4O2Rh(1+)*F6P(1-) In acetonitrile at 20℃; for 17h; Mannich Aminomethylation; enantioselective reaction;96%
chlorodifluoroacetic anhydride
2834-23-3

chlorodifluoroacetic anhydride

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

1-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-2-chloro-2,2-difluoroethanone

1-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-2-chloro-2,2-difluoroethanone

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 0 - 20℃; for 12h; Inert atmosphere;95%
1,4-benzoxazine
5735-53-5

1,4-benzoxazine

2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carbaldehyde

2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carbaldehyde

Conditions
ConditionsYield
In acetonitrile for 12h; Formylation;93%
(1-cyanopent-4-en-1-yl)(4-methoxyphenyl)carbamic chloride

(1-cyanopent-4-en-1-yl)(4-methoxyphenyl)carbamic chloride

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

N-(1-cyanopent-4-en-1-yl)-N-(4-methoxyphenyl)-2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carboxamide

N-(1-cyanopent-4-en-1-yl)-N-(4-methoxyphenyl)-2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carboxamide

Conditions
ConditionsYield
With 2,6-dimethylpyridine; potassium iodide In acetonitrile at 120℃; for 4h; Microwave irradiation;93%
C13H12N2O3

C13H12N2O3

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

C20H21N3O2

C20H21N3O2

Conditions
ConditionsYield
With bis[dichloro(pentamethylcyclopentadienyl)iridium(III)] In chloroform at 25℃; for 12h; Inert atmosphere; Sealed tube;93%
dichloroacethyl chloride
79-36-7

dichloroacethyl chloride

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

N-dichloroacetyl-3,4-dihydro-2H-1,4-benzoxazine
98730-07-5

N-dichloroacetyl-3,4-dihydro-2H-1,4-benzoxazine

Conditions
ConditionsYield
With sodium carbonate In benzene at 25℃;92%
carbon dioxide
124-38-9

carbon dioxide

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

4-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine
77901-22-5

4-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine

Conditions
ConditionsYield
With cyclopentadienyl iron(II) dicarbonyl dimer; phenylsilane; triphenylphosphine In acetonitrile at 100℃; under 760.051 Torr; for 36h; Schlenk technique; Sealed tube;92%
With diphenylsilane; [1,3-bis(2,4,6-trimethylphenyl)imidazol]-2-ylidene In N,N-dimethyl-formamide at 50℃; under 760.051 Torr; chemoselective reaction;64%
1,4-benzoxazine
5735-53-5

1,4-benzoxazine

prop-1-yne
74-99-7

prop-1-yne

4,4,6-trimethyl-2,3-dihydro-4H-1-oxa-3a-aza-phenalene

4,4,6-trimethyl-2,3-dihydro-4H-1-oxa-3a-aza-phenalene

Conditions
ConditionsYield
With ammonium hexafluorophosphate; dodecacarbonyl-triangulo-triruthenium In benzene at 95℃; for 24h;90%
Methyl 4-(bromomethyl)benzoate
2417-72-3

Methyl 4-(bromomethyl)benzoate

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

C17H17NO3

C17H17NO3

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 6h;89.7%
1,4-benzoxazine
5735-53-5

1,4-benzoxazine

erythro-3-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-3-phenylpropane-1,2-diol

erythro-3-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-3-phenylpropane-1,2-diol

Conditions
ConditionsYield
With tungsten hexa-ethoxide In acetonitrile at 55℃; for 24h; stereospecific reaction;89%
4-(2-cyclopropyl-5-oxazolyl)benzenesulfonyl chloride

4-(2-cyclopropyl-5-oxazolyl)benzenesulfonyl chloride

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

4-((4-(2-cyclopropanyloxazol-5-yl)phenyl)sulfonyl)-3,4-dihydrobenzo[b][1,4]oxazine

4-((4-(2-cyclopropanyloxazol-5-yl)phenyl)sulfonyl)-3,4-dihydrobenzo[b][1,4]oxazine

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 2h;88%
1,4-benzoxazine
5735-53-5

1,4-benzoxazine

trans ethyl 3-phenyloxirane-2-carboxylate

trans ethyl 3-phenyloxirane-2-carboxylate

ethyl (2RS,3RS)-3-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-2-hydroxy-3-phenylpropanoate

ethyl (2RS,3RS)-3-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-2-hydroxy-3-phenylpropanoate

Conditions
ConditionsYield
at 135℃; for 12h;87%
at 135℃; for 12h;87%
1,4-benzoxazine
5735-53-5

1,4-benzoxazine

benzenesulfonyl chloride
98-09-9

benzenesulfonyl chloride

4-(phenylsulfonyl)-3,4-dihydro-2Hbenzo[b][1,4]oxazine
1090557-10-0

4-(phenylsulfonyl)-3,4-dihydro-2Hbenzo[b][1,4]oxazine

Conditions
ConditionsYield
With triethylamine In benzene at 20℃; for 12h; Inert atmosphere;87%
1,1,1,3',3',3'-hexafluoro-propanol
920-66-1

1,1,1,3',3',3'-hexafluoro-propanol

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

2-(3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)-1,1,1,3,3,3-hexafluoropropan-2-ol
71280-80-3

2-(3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)-1,1,1,3,3,3-hexafluoropropan-2-ol

Conditions
ConditionsYield
With piperidin-1-yl benzoate; copper(II) acetate tetrahydrate at 70℃; for 5h;87%
With [2,2]bipyridinyl; oxygen; copper(II) bis(trifluoromethanesulfonate); sodium carbonate at 50℃; under 760.051 Torr; for 3.5h; Schlenk technique; Green chemistry; regiospecific reaction;63%
C15H12FNO2
1479051-52-9

C15H12FNO2

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

1-(3,4-dihydro-2H-1,4-benzoxazin-4-yl)-3-(6-fluoro-9H-carbazol-2-yloxy)-2-propanol
1479050-56-0

1-(3,4-dihydro-2H-1,4-benzoxazin-4-yl)-3-(6-fluoro-9H-carbazol-2-yloxy)-2-propanol

Conditions
ConditionsYield
In isopropyl alcohol Reflux;86%
1,4-benzoxazine
5735-53-5

1,4-benzoxazine

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

(2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)(1H-imidazol-1-yl)methanone

(2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)(1H-imidazol-1-yl)methanone

Conditions
ConditionsYield
In dichloromethane at 20℃; for 6h; Cooling with ice;86%
1,4-benzoxazine
5735-53-5

1,4-benzoxazine

Cyclohexanecarboxylic acid
98-89-5

Cyclohexanecarboxylic acid

4-cyclohexyl-3,4-dihydro-2H-benzo[b][1,4]oxazine

4-cyclohexyl-3,4-dihydro-2H-benzo[b][1,4]oxazine

Conditions
ConditionsYield
With 9-(2-chlorophenyl)acridine; di-tert-butyl peroxide; copper(II) hexafluoroacetylacetonate at 35℃; for 36h; Inert atmosphere; Irradiation;86%
carbon dioxide
124-38-9

carbon dioxide

1,4-benzoxazine
5735-53-5

1,4-benzoxazine

2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carbaldehyde

2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carbaldehyde

Conditions
ConditionsYield
With cyclopentadienyl iron(II) dicarbonyl dimer; tributylphosphine; phenylsilane In acetonitrile at 30℃; under 760.051 Torr; for 24h; Schlenk technique; Sealed tube;85%

5735-53-5Relevant articles and documents

Lithiation of N-protected-dihydro-1,4-benzoxazines

Lu, Yansong J.,Hu, Bin,Prashad, Mahavir,Kabadi, Shaum,Repic, Oljan,Blacklock, Thomas J.

, p. 1125 - 1127 (2006)

Lithiation of N-protected-2,3-dihydro-1,4-benzoxazines is described. Lithiation of N-(tert-butoxycarbonyl)-2,3-dihydro-1,4-benzoxazine (1) with BuLi/TMEDA occurred in the α-position to nitrogen on the heterocyclic ring, leading to the unexpected ring-opened product 3. On the other hand, lithiation of N-methyl-2,3-dihydro-1,4-benzoxazine (4) took place at the oxygen-adjacent orito-position of the aromatic ring.

Synthesis, docking, 3-D-qsar, and biological assays of novel indole derivatives targeting serotonin transporter, dopamine D2 receptor, and mao-a enzyme: In the pursuit for potential multitarget directed ligands

Alarcón-Espósito, Jazmín,Araya-Maturana, Ramiro,Cabezas, David,Cerda-Cavieres, Christopher,Chung, Hery,Iturriaga-Vásquez, Patricio,Mella-Raipán, Jaime,Ojeda-Gómez, Claudia,Pessoa-Mahana, Carlos D.,Pessoa-Mahana, Hernán,Quiroz, Gabriel,Reyes-Parada, Miguel,Rodríguez-Lavado, Julio,Saitz, Claudio

, (2020/10/18)

A series of 27 compounds of general structure 2,3-dihydro-benzo[1,4]oxazin-4-yl)-2-{4-[3-(1H-3indolyl)-propyl]-1-piperazinyl}-ethanamides, Series I: 7(a-o) and (2-{4-[3-(1H-3-indolyl) -propyl]-1-piperazinyl}-acetylamine)-N-(2-morfolin-4-yl-ethyl)-fluorinated benzamides Series II: 13(a-l) were synthesized and evaluated as novel multitarget ligands towards dopamine D2 receptor, serotonin transporter (SERT), and monoamine oxidase-A (MAO-A) directed to the management of major depressive disorder (MDD). All the assayed compounds showed affinity for SERT in the nanomolar range, with five of them displaying Ki values from 5 to 10 nM. Compounds 7k, Ki = 5.63 ± 0.82 nM, and 13c, Ki = 6.85 ± 0.19 nM, showed the highest potencies. The affinities for D2 ranged from micro to nanomolar, while MAO-A inhibition was more discrete. Nevertheless, compounds 7m and 7n showed affinities for the D2 receptor in the nanomolar range (7n: Ki = 307 ± 6 nM and 7m: Ki = 593 ± 62 nM). Compound 7n was the only derivative displaying comparable affinities for SERT and D2 receptor (D2/SERT ratio = 3.6) and could be considered as a multitarget lead for further optimization. In addition, docking studies aimed to rationalize the molecular interactions and binding modes of the designed compounds in the most relevant protein targets were carried out. Furthermore, in order to obtain information on the structure-activity relationship of the synthesized series, a 3-D-QSAR CoMFA and CoMSIA study was conducted and validated internally and externally (q2 = 0.625, 0.523 for CoMFA and CoMSIA and r2ncv = 0.967, 0.959 for CoMFA and CoMSIA, respectively).

Silicon hydrogenation reaction method of organic boron and inorganic alkali catalysis amide (by machine translation)

-

Paragraph 0107-0113; 0130-0133, (2020/08/18)

The method is characterized in that organic boron and inorganic bases are used as catalysts, silane is used as a reducing agent, primary amide is reduced to primary amine or dehydration dinitrile, the secondary amide is reduced to a secondary amine or aldimine, and the tertiary amide is reduced to tertiary amine. The method has the advantages of simple operation, mild reaction conditions, wide substrate universality, good functional group compatibility and the like, and has the characteristics of good stability, cheap and accessible catalyst, simple and convenient operation, high practicality and the like. (by machine translation)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5735-53-5